By 2020, the U.S. infusion therapy device market size was valued at $2.9 billion, with over 230 million primary IV sets sold every year. Despite COVID19, the market size is expected to increase at a compound annual growth rate (CAGR) of 2.6% to reach $3.5 billion in 2026. Throughout this medical market research, we analyzed

The full report suite on the Australian market for infusion therapy devices includes infusion pumps, intravenous sets (IV sets), needleless connectors (NLCs), stopcocks for infusion systems and infusion sets designed for blood transfusion (blood transfusion sets).

The full report suite on the Japanese market for infusion therapy devices includes infusion pumps, intravenous sets (IV sets), needleless connectors, stopcocks for infusion systems and infusion sets designed for blood transfusion (blood transfusion sets).

The full report suite on the South Korean market for infusion therapy devices includes infusion
pumps, intravenous sets (IV sets), needleless connectors, stopcocks for infusion systems and
infusion sets designed for blood transfusion (blood transfusion sets).

The full report suite on the Chinese market for infusion therapy devices includes infusion pumps,
intravenous sets (IV sets), needleless connectors, stopcocks for infusion systems and infusion sets
designed for blood transfusion (blood transfusion sets).

The full report suite on the Indian market for infusion therapy devices includes infusion pumps,
intravenous sets (IV sets), needleless connectors, stopcocks for infusion systems and infusion sets
designed for blood transfusion (blood transfusion sets).

Infusion therapy devices are used for administering fluids or medication directly into a vein. Some disease states are too severe to be treated with oral medications, and must be treated intravenously. This is generally facilitated with an intravenous (IV) bag that is connected to a catheter inserted into a vein using plastic IV tubing. Infusion can be achieved simply through gravity drip, which uses gravity to introduce fluids into a patient’s vasculature or through the use of an electronic pump. Initially, connecting tubing to the catheter inserted into the patient was done by spiking a needle into a connector on the catheter. However, due to concerns over needlestick injuries and the increased incidence of infection when infusing with non-closed systems, some markets have shifted towards the use of needle-free connectors. Physicians now have the option of connecting the tubing to the inserted catheter using male luer connections and other connectors that accept blunt cannulas.
In 2013, the Asia-Pacific market for infusion therapy devices included volumetric infusion pumps, syringe infusion pumps, disposable infusion pumps, IV tubing sets, needleless connectors and stopcocks. These categories are segmented based on the type of displacement used, the type of infusion being performed and the type of medication and fluid infused. There are several other accessories commonly used during infusion therapy, such as disinfecting caps and three-way stopcocks; however, these aren’t included in the total market value for this report.
Additionally, needleless connectors are not included in the overall market value in this chapter, as they are present only in Australia and Japan, but not in South Korea. The information for each needleless connector market can be found in each country’s respective chapter.